Amneal Pharmaceuticals, Inc. (AMRX)
Largest Insider Buys in Sector
AMRX Stock Price History Chart
AMRX Stock Performance
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in …
Insider Activity of Amneal Pharmaceuticals, Inc.
Over the last 12 months, insiders at Amneal Pharmaceuticals, Inc. have bought $0 and sold $2.49M worth of Amneal Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Amneal Pharmaceuticals, Inc. have bought $2.94M and sold $2.98M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 50,000 shares for transaction amount of $210,500 was made by Patel Gautam (director) on 2021‑12‑17.
List of Insider Buy and Sell Transactions, Amneal Pharmaceuticals, Inc.
| 2024-11-22 | Sale | director | 17,058 0.0037% | $8.38 | $142,946 | -2.26% | ||
| 2024-11-22 | Sale | director | 33,229 0.0072% | $8.34 | $277,130 | -2.26% | ||
| 2024-11-21 | Sale | director | 6,771 0.0015% | $8.41 | $56,944 | -0.84% | ||
| 2024-11-21 | Sale | SVP, Chief Legal Officer | 13,665 0.003% | $8.40 | $114,786 | -0.84% | ||
| 2024-11-15 | Sale | SVP, Chief Legal Officer | 43,657 0.0136% | $8.61 | $375,887 | -2.36% | ||
| 2024-08-15 | Sale | Executive Vice President | 40,225 0.0136% | $7.85 | $315,766 | 0.00% | ||
| 2024-08-14 | Sale | Executive Vice President | 22,486 0.0076% | $7.81 | $175,616 | 0.00% | ||
| 2024-08-14 | Sale | Executive Vice President | 100,000 0.0335% | $7.75 | $775,000 | 0.00% | ||
| 2024-05-17 | Sale | director | 23,447 0.0076% | $6.73 | $157,728 | +21.63% | ||
| 2024-05-16 | Sale | director | 14,553 0.0047% | $6.76 | $98,378 | +22.70% | ||
| 2023-08-11 | Sale | Executive Vice President | 29,302 0.0099% | $4.13 | $120,921 | +37.66% | ||
| 2022-12-12 | Sale | director | 3.88M 2.4609% | $2.34 | $9.1M | +10.66% | ||
| 2021-12-17 | director | 50,000 0.0331% | $4.21 | $210,500 | -22.01% | |||
| 2021-12-16 | President & Co-CEO | 50,000 0.0343% | $4.25 | $212,500 | -19.83% | |||
| 2021-12-16 | Co-CEO | 50,000 0.0343% | $4.25 | $212,500 | -19.83% | |||
| 2021-12-15 | Sale | Executive Vice President | 2,000 0.0013% | $3.95 | $7,900 | -19.20% | ||
| 2021-12-15 | President & Co-CEO | 100,000 0.067% | $4.13 | $413,000 | -19.20% | |||
| 2021-12-15 | Co-CEO | 100,000 0.067% | $4.13 | $413,000 | -19.20% | |||
| 2021-12-02 | Sale | Executive Vice President | 1,500 0.001% | $4.10 | $6,150 | -18.11% | ||
| 2021-03-15 | Sale | SVP, Specialty Commercial | 36,330 0.0097% | $2.75 | $99,908 | -26.36% |
Insider Historical Profitability
| Kiely John | director | 267175 0.0578% | $7.85 | 1 | 1 | +5.19% |
| BOYER ANDREW S | Executive Vice President | 256670 0.0556% | $7.85 | 2 | 3 | <0.0001% |
| Patel Chintu | Co-CEO | 512566 0.111% | $7.85 | 6 | 0 | +5.05% |
| Patel Chirag K. | President & Co-CEO | 512566 0.111% | $7.85 | 6 | 0 | +5.05% |
| MEISTER PAUL M | director | 353649 0.0766% | $7.85 | 2 | 0 | +58.69% |
Institutional Investor Ownership
| The Vanguard Group | $83.19M | 4.45 | 13.73M | +0.63% | +$520,226.76 | <0.01 | |
| Tpg Gp A Llc | $74.71M | 3.99 | 12.33M | 0% | +$0 | 1.45 | |
| Fosun International Ltd | $74.62M | 3.99 | 12.31M | -42.78% | -$55.79M | 37.59 | |
| Helm Capital Management LLC | $57.82M | 3.09 | 9.54M | +19.27% | +$9.34M | 1.71 | |
| BlackRock | $55.53M | 2.97 | 9.16M | +3.59% | +$1.93M | <0.01 |